Cargando…

Alanyl-glutamine supplementation for Clostridioides difficile infection treatment (ACT): a double-blind randomised controlled trial study protocol

INTRODUCTION: Clostridioides difficile is the leading cause of healthcare-associated infections in the USA, with an estimated 1 billion dollars in excess cost to the healthcare system annually. C. difficile infection (CDI) has high recurrence rate, up to 25% after first episode and up to 60% for suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warren, Cirle A, Shin, Jae Hyun, Bansal, Ekta N, Costa, Deiziane V D S, Wang, Xin Qun, Wu, Martin, Swann, Jonathan R, Behm, Brian W, Targonski, Paul V, Archbald-Pannone, Laurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Research Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357635/ https://www.ncbi.nlm.nih.gov/pubmed/37474181 http://dx.doi.org/10.1136/bmjopen-2023-075721

Ejemplares similares

Host and Clostridioides difficile-Response Modulated by Micronutrients and Glutamine: An Overview
por: Loureiro, Andréa V., et al.
Publicado: (2022)

398. Post-Infectious Irritable Bowel Syndrome in Patients Referred to a Complicated Clostridioides difficile Clinic
por: Pham, Natalie, et al.
Publicado: (2022)

236. Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities
por: Tillotson, Glenn S, et al.
Publicado: (2022)

Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis
por: Shin, Jae Hyun, et al.
Publicado: (2019)

Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes
por: Madden, Gregory R., et al.
Publicado: (2022)

Long-term Care Resident Quality of Life 1 Year Following Initial COVID-19 Vaccination
por: Ryall, Amy, et al.
Publicado: (2023)

709. Post-Clostridioides difficile Infection Neuroinflammatory Response in an Animal Model
por: Yang, Suemin E, et al.
Publicado: (2023)

Glutamine and Alanyl-Glutamine Increase RhoA Expression and Reduce Clostridium difficile Toxin-A-Induced Intestinal Epithelial Cell Damage
por: Santos, Ana A. Q. A., et al.
Publicado: (2013)

Survey of C. difficile-Specific Infection Control Policies in Local Long-Term Care Facilities
por: Archbald-Pannone, Laurie
Publicado: (2014)

Effects of adenosine A(2A )receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice
por: Warren, Cirle Alcantara, et al.
Publicado: (2012)

Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent Clostridioides difficile Infection in Older Adults With Underlying Comorbidities
por: Tillotson, Glenn, et al.
Publicado: (2022)

Adenosine receptors differentially mediate enteric glial cell death induced by Clostridioides difficile Toxins A and B
por: Costa, Deiziane V. S., et al.
Publicado: (2023)

697. Outcomes of Tigecycline Use for Clostridioides difficile Infection: A Case Series of 28 Patients
por: Phillips, Emma C, et al.
Publicado: (2021)

The absence of surface D-alanylation, localized on lipoteichoic acid, impacts the Clostridioides difficile way of life and antibiotic resistance
por: Lacotte, Pierre-Alexandre, et al.
Publicado: (2023)

S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Clostridioides difficile Infection by Modulating Inflammatory Response
por: Costa, Deiziane V. S., et al.
Publicado: (2021)

Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review
por: Fernandez-Cotarelo, Maria-Jose, et al.
Publicado: (2023)

Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
por: Zhu, Jiangming, et al.
Publicado: (2020)

Intervention and Mechanisms of Alanyl-glutamine for Inflammation, Nutrition, and Enteropathy: A Randomized Controlled Trial
por: Moore, Sean R., et al.
Publicado: (2020)

Hospitalized Older Patients with Clostridioides difficile Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant
por: Shin, Jae Hyun, et al.
Publicado: (2021)

Clostridioides difficile colonization among very young children in resource-limited settings
por: Brennhofer, Stephanie A., et al.
Publicado: (2022)

Role of probiotics in preventing Clostridioides difficile infection in older adults: an integrative review
por: Barbosa, Maria Lucianny Lima, et al.
Publicado: (2023)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

Role of Pannexin-1-P2X7R signaling on cell death and pro-inflammatory mediator expression induced by Clostridioides difficile toxins in enteric glia
por: Loureiro, Andrea V., et al.
Publicado: (2022)

Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats
por: Karimipour, Mojtaba, et al.
Publicado: (2018)

Effects of alanyl-glutamine supplementation on the small intestinal mucosa barrier in weaned piglets
por: Xing, Shen, et al.
Publicado: (2017)

Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice
por: Araújo, C.V., et al.
Publicado: (2015)

Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
por: Herzog, Rebecca, et al.
Publicado: (2017)

Perceptions and Uses of Telehealth in the Care of Older Adults
por: Wardlow, Liane, et al.
Publicado: (2023)

2429. Whole-genome Sequencing of Healthcare-Onset C. difficile Infection (HO-CDI) Cases Shows Widespread Presence of Antimicrobial Resistance Genes
por: Hyun Shin, Jae, et al.
Publicado: (2019)

754. A Two-step Testing Algorithm for Hospital-onset Clostridioides difficile Infection (CDI) Reduces Prescribing of C. difficile (CD) Therapy but Its Ability to Guide Treatment Decisions Remains Unclear
por: Dolan, Mackenzie, et al.
Publicado: (2021)

L-alanyl-L-glutamine ingestion maintains performance during a competitive basketball game
por: Hoffman, Jay R, et al.
Publicado: (2012)

Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine
por: Wiesenhofer, Florian M., et al.
Publicado: (2019)

Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats
por: da Rosa, Carlos Vinicius D., et al.
Publicado: (2015)

Editorial: Microbial interactions of Clostridioides difficile
por: Goh, Shan, et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Examination of the efficacy of acute L-alanyl-L-glutamine ingestion during hydration stress in endurance exercise
por: Hoffman, Jay R, et al.
Publicado: (2010)

Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures
por: Herzog, Rebecca, et al.
Publicado: (2018)

Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid
por: Bartosova, Maria, et al.
Publicado: (2020)

Alanyl-glutamine protects the intestinal barrier function in trained rats against the impact of acute exhaustive exercise
por: Freitas, A.K.L., et al.
Publicado: (2020)

Clostridioides difficile Toxin A-Induced Wnt/β-Catenin Pathway Inhibition Is Mediated by Rac1 Glucosylation
por: Martins, Conceição S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15f0q9jo5bq50c1r79rbfmojp2